| Title |
Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, July 2018
|
| DOI | 10.2147/tcrm.s147381 |
| Pubmed ID | |
| Authors |
Dazhi Liu, Michael Offin, Stephen Harnicar, Bob T Li, Alexander Drilon |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 91 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 15% |
| Researcher | 13 | 14% |
| Student > Bachelor | 11 | 12% |
| Student > Ph. D. Student | 7 | 8% |
| Other | 6 | 7% |
| Other | 13 | 14% |
| Unknown | 27 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 24% |
| Biochemistry, Genetics and Molecular Biology | 18 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 11% |
| Nursing and Health Professions | 3 | 3% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 9 | 10% |
| Unknown | 26 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#5,449,088
of 25,385,509 outputs
Outputs from Therapeutics and Clinical Risk Management
#275
of 1,323 outputs
Outputs of similar age
#96,461
of 341,606 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#10
of 31 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,606 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.